EP1948076A1 - Lest intragastrique - Google Patents

Lest intragastrique

Info

Publication number
EP1948076A1
EP1948076A1 EP06827313A EP06827313A EP1948076A1 EP 1948076 A1 EP1948076 A1 EP 1948076A1 EP 06827313 A EP06827313 A EP 06827313A EP 06827313 A EP06827313 A EP 06827313A EP 1948076 A1 EP1948076 A1 EP 1948076A1
Authority
EP
European Patent Office
Prior art keywords
space filler
gastric
filler device
stomach
gastric space
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06827313A
Other languages
German (de)
English (en)
Other versions
EP1948076A4 (fr
Inventor
Andrew H. Cragg
Rodolfo C. Quijano
Bobby Purkait
Hosheng Tu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reshape Medical LLC
Original Assignee
ReShape Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/263,302 external-priority patent/US20070100368A1/en
Priority claimed from US11/262,614 external-priority patent/US20070100367A1/en
Priority claimed from US11/315,925 external-priority patent/US20070100369A1/en
Application filed by ReShape Medical Corp filed Critical ReShape Medical Corp
Publication of EP1948076A1 publication Critical patent/EP1948076A1/fr
Publication of EP1948076A4 publication Critical patent/EP1948076A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/003—Implantable devices or invasive measures inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/003—Implantable devices or invasive measures inflatable
    • A61F5/0033—Implantable devices or invasive measures inflatable with more than one chamber
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/0036—Intragastrical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/0036—Intragastrical devices
    • A61F5/004—Intragastrical devices remotely adjustable
    • A61F5/0043—Intragastrical devices remotely adjustable using injection ports
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/044—Oesophagi or esophagi or gullets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F2005/0016—Implantable devices or invasive measures comprising measuring means
    • A61F2005/002—Implantable devices or invasive measures comprising measuring means for sensing mechanical parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F2005/0016—Implantable devices or invasive measures comprising measuring means
    • A61F2005/0023—Implantable devices or invasive measures comprising measuring means for sensing chemical parameters

Definitions

  • the present disclosure is generally related to implantable weight control devices. More particularly, the present disclosure is related to an intragastric space filler device 19 which is retrievably implantable in a patient.
  • Gastric space fillers used for achieving loss of weight in extremely obese persons have been known in the prior art. All gastric space fillers utilized for this purpose function on the principle that an empty bag or space filler is placed into the stomach through the esophagus. Thereafter, the bag or space filler is filled (fully or partially) with a suitable insufflation fluid, such as saline solution, through a filler tube or catheter which is inserted into the stomach through the mouth or the nose. The space filler occupies space in the stomach thereby leaving less room available for food and creating a feeling of satiety for the obese person. Clinical experience of the prior art has shown that for many obese patients the intragastric space fillers significantly help to control appetite and accomplish weight loss.
  • a suitable insufflation fluid such as saline solution
  • intragastric bags or space fillers described in the prior art, one type remains connected to a filler tube during the entire time period while the space filler is in the stomach.
  • the tube is introduced into the patient's stomach through the nostrils.
  • Such an intragastric space filler is described, for example, in U.S. Pat. No. 4,133,315.
  • Garren et al. in U.S. Pat. No. 4,416,267 and 4,899,747 discloses a stomach insert for treating obesity in humans by reducing the stomach volume comprising a flexible torus-shaped inflatable space filler having a central opening extending therethrough. At least a portion of the space filler has a self- sealing substance to facilitate puncture thereof with a needle for inflating the space filler and sealing off the puncture upon removal of the needle.
  • the method herein comprises positioning the space filler inside the stomach of the person being treated for obesity so as to reduce the stomach volume.
  • the Garren et al. stomach insert works satisfactorily to control the appetite.
  • the insert may deflate and collapse unexpectedly resulting in obstructing the pylorus or small intestines. It appears desirable to have a gastric space filler device 19 that yields some noticeable warning and prompts timely removal of the implant from the patient.
  • Non-surgical approaches for the treatment of obesity include voluntary dieting which is often unsuccessful since most persons do not possess sufficient willpower to limit the intake of food.
  • Other approaches include the use of stomach fillers such as methylcellulose, often taken in the form of tablets. The methylcellulose expands in the stomach leaving the person with a filled-up feeling.
  • inflatable bag and tube combinations have been proposed wherein the bag is swallowed into the stomach and the tube attached thereto is used to periodically inflate the bag, particularly just prior to mealtime or during the meal. Once the person has eaten, the bag can be deflated all at once, or it can be deflated gradually over a period of a few hours so as to simulate the condition of digestion occurring and the gradual reduction of stomach contents.
  • U.S. Pat. No. 4,133,315 issued on January 9, 1979 discloses such an inflatable bag and tube combination.
  • the tubing remains attached to the bag and inside the esophagus of the person being treated. These tubes are often the cause of erosions and ulcerations of the esophagus.
  • This patent also discloses a gastrotomy method wherein the permanently attached tube used to distend the stomach bag extends through an opening in the stomach wall as well as an opening in the abdomen.
  • U.S. Pat. No. 4,246,893 issued on January 27, 1981 discloses an inflatable bag and tube combination which is surgically positioned outside and adjacent to the stomach. Upon inflation of the bag, the upper abdomen is distended and the stomach compressed to thereby produce a sense of satiety which reduces the person's desire to ingest food.
  • U.S. Pat. No. 4,598,699 issued on July 8, 1996 discloses an endoscopic instrument for removing an inflated insert from the stomach cavity of a person being treated for obesity comprising an elongated flexible tube having passageways therein and a holding device at the distal end of the flexible tube that is constructed and arranged to grasp and stabilize the inflated stomach insert.
  • 6,826,428 provides a method of regulating gastrointestinal action using a stimulatory electrode and a sensor to provide retrograde feedback control of electrical stimulation to the GI tract or to the stomach.
  • U.S. Pat. No. 4,694,827 issued on September 22, 1987 discloses a balloon insertable and inflatable in the stomach to deter ingestion of food and having, when inflated, a plurality of smooth-surfaced convex protrusions disposed to permit engagement of the stomach wall by the balloon only at spaced localities, for minimizing mechanical trauma of the stomach wall by the balloon.
  • U.S. Pat. No. 6,746,460 issued on June 8, 2004 discloses an expandable device that is inserted into the stomach of the patient that is maintained within by anchoring or otherwise fixing the expandable device to the stomach walls.
  • Such expandable devices have tethering regions for attachment to the one or more fasteners which can be configured to extend at least partially through one or several folds of the patient's stomach wall.
  • Such fasteners can be formed in a variety of configurations, e.g., helical, elongate, ring, clamp, and they can be configured to be non-piercing.
  • One aspect of the invention discloses a gastric space filler device 19 with programmed volume-adjustable capability or warning signals for device potential failure.
  • a gastric space filler device effective for reducing the stomach volume comprising an inflatable space filler and a safety element secured to said space filler, wherein the safety element comprises a mechanism to yield a noticeable signal enabling removal of said space filler.
  • some aspects of the present disclosure relate to a gastric space filler system for treating obesity in a patient by reducing the stomach volume comprising at least two flexible inflatable space fillers secured to each other, a first space filler being inflatable to a volume inside the stomach and not in fluid communication with the other remaining space fillers, wherein at least a portion of the first-space filler is made of a biodegradable material.
  • the gastric space filler device of the present disclosure is characterized with little or minimal effects of bowel obstruction, erosion, perforation, and infection to a patient.
  • the space filler generally approximates the shape of the stomach and accomplishes more complete space filling (up to 95%of stomach volume).
  • the space filler system comprises pressure sensor element for transmitting internal pressure readings of one space filler to a receiver or controller.
  • a pressure sensor element is mounted on a first of the at least two space fillers of the gastric space filler system for sensing an internal pressure of the first space filler.
  • the pressure sensor element further comprises a transmitter for wirelessly transmitting the measured internal pressure signal to a receiver outside a body of the patient. The measured internal pressure is compared to a pre-determined threshold pressure for signaling removal of the filler system.
  • the pressure sensor element may be substituted by a pH sensor, a flow-rate sensor, a temperature sensor, an electrolyte sensor, or the like.
  • two of the at least two space fillers of the gastric space filler system are configured to be in tandem inside the stomach pouch or are configured to be substantially parallel to each other.
  • at least one of the two space fillers of the gastric space filler system is anchored to an inner wall of the stomach.
  • the anchoring action is arranged and configured to activate the anchoring mechanism when the space filler is inflated while contacting the inner wall of the stomach, and to reverse the anchoring mechanism when the filler is deflated.
  • At least a portion of the at least two space fillers is ultrasonically visible.
  • One method of visualization is to have ultrasonically visible air bubble at or on part of the space filler.
  • Another method is to incorporate ultrasonically visible contrast agent at or on part of the space filler.
  • the gastric space filler device is configured to be deliverable through an esophagus of the patient.
  • at least a portion of an external surface of the space filler is treated with an anti- acid substance, corrosion-resistant substance, or anti-adhesion substance, wherein the substance comprises polytetrafluoroethylene, inert material, or another biocompatible biological material (such as albumin, melatonin, phosphorylcholine, or protein).
  • Methods of treating the surface include coating, painting, dipping, impregnation, and the like.
  • aspects of the present disclosure provide a gastric space filler device for treating obesity in a patient by reducing the stomach volume comprising an inflatable space filler and a safety element secured to the space filler, wherein the safety element comprises a mechanism to yield a noticeable signal for causing a removal of the space filler.
  • a gastric space filler device for treating obesity in a patient by reducing a stomach volume comprising an inflatable space filler with a first reference shape at an inflated state and means for substantially maintaining the first reference shape at a deflated state.
  • the means for substantially maintaining the first reference shape at the deflated state is to provide a spiral supportive ridgeline onto the space filler, wherein the spiral ridgeline may comprise a material similar to material of the space filler.
  • the means for substantially maintaining the first reference shape at the deflated state is to provide a plurality of cross bars inside an interior space of the splice filler.
  • a gastric space filler device for treating obesity in a patient by reducing a stomach volume comprising an inflatable space filler with a first cross-sectional circumference dimension at an inflated state and means for maintaining a second cross- sectional circumference dimension with at least 75 percent of the first circumference dimension at a deflated state.
  • any of the at least two space fillers of the gastric space filler system have a central opening extending therethrough.
  • one of the at least two space fillers is fabricated from polyurethane sheet material.
  • the polyurethane sheet material comprises a single layer.
  • Other polymer sheet material compliant (for example, silicone or Nylon) or non-compliant (for example, polyethylene or polytetrafluoroethylene), may also be suitable for the intended purposes.
  • the biodegradable material for the gastric space filler system is selected from a group consisting of polymers or copolymers of lactide, glycolide, caprolactone, polydioxanone, trimethylene carbonate, polyorthoesters, and polyethylene oxide.
  • one of the at least two space fillers is made of a non-biodegradable material selected from a group consisting of polyester, polypropylene, Nylon, polyethylene, co-polymers thereof, and the like.
  • aspects of the present disclsoure relate to a gastric space filler device for treating obesity in a patient by reducing the stomach volume comprising at least two inflatable space fillers secured to each other, wherein each inflatable space filler comprises an individual infusing port.
  • the gastric space filler device further comprises a pressure sensor element for sensing an internal pressure of a first filler of the at least two inflatable space fillers, wherein the pressure sensor element further comprises a transmitter for wirelessly transmitting the sensed internal pressure to a receiver outside a body of the patient.
  • the gastric space filler device comprises three or four space fillers.
  • At least one space filler of the gastric space filler device is ultrasonically visible or detectable, or comprises an ultrasonic transducer configured for emitting an ultrasonic signal.
  • a gastric space filler device for treating obesity in a patient by reducing the stomach volume comprising at least one inflatable elongate space filler, wherein the inflatable space filler comprises a first end-ring at a first end and a second end-ring at a second end of the elongate filler.
  • the first end-ring and the second end- ring are sized and configured to stent the filler against an internal wall of the stomach.
  • an internal space of the filler is filled with swellable hydrogel, wherein the hydrogel is a temperature sensitive or pH sensitive hydro gel.
  • a gastric space filler device for treating obesity in a patient by reducing the stomach volume comprising at least one inflatable space filler, wherein at least one inflatable space filler comprises an infusing port.
  • the gastric space filler device may be retrieved from a stomach by a ring system, a grasping system, a magnetic system, or a suction system.
  • the retrieval system is preferably coupled with puncturer for puncturing and reducing the volume of the gastric space filler device.
  • the volume of a substance injected into each space filler is adjustable, including remotely adjustable.
  • the volume is adjusted by one of infusing additional substance, infusing a different substance, reallocating substance between inflatable space fillers, or introducing a chemical expansion agent.
  • At least one space filler is comprised of a self-sealing surface element to allow for puncture from an exterior source, but remain sealed after the exterior source is removed.
  • FIG. 1 shows an embodiment of a gastric space filler device with two space fillers secured to and in parallel to each other.
  • FIG. 2 shows an embodiment of a first space filler of the two space fillers in FIG. 1 with a central passageway therethrough.
  • FIG. 3 shows an embodiment of a gastric space filler device with two space fillers secured to and in tandem to each other.
  • FIG. 4 shows an embodiment of a gastric space filler device having an inflatable space filler with a support mechanism thereto.
  • FIG. 5 shows an embodiment of a cross-sectional view of the support mechanism of FIG. 4.
  • FIG. 6 shows an embodiment of one embodiment of a gastric space filler device with two connected expandable elements.
  • FIG. 7 shows an embodiment of an illustration of gastric space filler device of FIG. 6 in a recipient.
  • FIG. 8 shows an embodiment of a gastric space filler device comprising a shape retention mechanism.
  • FIG. 9 shows an embodiment of a perspective view of gastric space filler device of FIG. 8.
  • FIG. 10 shows an embodiment of an adjustable gastric space filler device.
  • FIG. 11 shows an embodiment of an adjustable gastric space filler device.
  • FIG. 12A shows one embodiment of a multi-balloon space filler device.
  • FIG. 12B shows an alternate embodiment of a multi-balloon space filler device.
  • FIG. 13A shows an embodiment of a free-floating space filler device.
  • FIG. 13B shows an embodiment of a simulated placement of the space filler device of FIG. 13A in a stomach.
  • FIG. 14A shows an embodiment of a non-floating space filler device.
  • FIG. 14B shows an embodiment of a vertical view of the non-floating space filler device of FIG. 14A.
  • FIG. 14C shows an embodiment of a simulated placement of the space filler device of FIG. 14A in a stomach.
  • FIG. 15 shows an embodiment of a delivery apparatus for non- surgically implanting a gastric space filler device.
  • FIG. 16 shows an embodiment of one embodiment of removing a gastric space filler device from the patient.
  • FIG. Yj shows an embodiment of a pressure sensor element mounted on a space filler in accordance with the principles of the present disclosure.
  • Embodiments of the present disclosure described below relate particularly to an intragastric space filler device comprising at least one space filler for reducing the stomach volume and one space filler made of biodegradable material, wherein the biodegradable material (that is, at least a portion of the space filler is made of biodegradable material) is used as a warning signal for timely removal of gastric space filler device.
  • the biodegradable material that is, at least a portion of the space filler is made of biodegradable material
  • the stomach is a J-shaped organ with very active muscles.
  • Muscles of the stomach expand and contract depending on how much food is in the stomach. This contraction mechanically breaks down the food.
  • the purpose of this breakdown is to increase the available surface area for the chemicals to act on it.
  • the gastric glands of the stomach secrete enzymes that perform chemical breakdown, partly digesting the proteins. Pepsin is the enzyme that breakdowns protein.
  • the gastric gland also secretes hydrochloric acid that kills almost all the bacteria in the food, and helps digestion by breakdown of acid- labile proteins. It also secretes mucus that protects the stomach wall from the hydrochloric acid.
  • the structure of the stomach is quite unique. It can be divided into four subdivisions: the cardia, the fundus, the body, and the pylorus.
  • the cardia is the region that is closest to the heart and is where the esophagus connects to the stomach.
  • the fundus is the region that curves above the rest of the stomach
  • the body of the stomach is the central region and comprises the majority of the organ.
  • the pylorus is the region that is connected to the small intestine.
  • the cardia and the pylorus each have sphincter muscles that regulate the movement of food and fluids.
  • the volume of the human stomach varies depending on the person. Generally, human stomachs have a volume about one liter. Because the stomach has the ability to expand, however, it can hold up to four liters.
  • the device of the present disclosure intends to provide mechanisms for preventing or avoiding migration, bowel obstruction, bleeding diathesis, erosion, perforation of stomach or any internal organs, and the like. Some complications are acceptable if the benefits of device design far outweigh the risks, such as access site related minor complications, some patient discomfort due to the presence of the device or due to access site related issues, nausea, feeling of bloating, and the like.
  • Gastric space filler device is capable of filling up to 95% of stomach, and is self-adjustable or portable. It may be dialed or programmed to adjust the space filler according to input signals of pressure, volume, pH, temperature, size, electrolyte properties, etc.
  • gastric space filler device is also equipped with failure detection mechanism, such as bleeding/ulceration detection, migration limiter, etc.
  • adjustable gastric space filler device is retrievable. The device may be designed and arranged for restrictive food intake with custom shape that either adapts to or is made to the shape and size of a given patient's stomach.
  • Some aspects of the present disclosure provide a method for determining fluid pressure within a patient or within a space filler comprising: (a) providing a wireless capacitive MEMS chip sensor comprising an inductance coil and spaced apart capacitor plates as an inductive-capacitive circuit, with the fluid in pressure contact with one of the capacitive plates; (b) inducing a mutual inductance as an external signal into the sensor to produce the resonant frequency response as an internal signal from the sensor; and (c) determining the fluid pressure within the patient externally of the patient from the internal signal as a function of the resonant frequency response from the sensor resulting from a change in capacitance of the sensor due to a variation in the spacing of the plates produced by the fluid pressure of the fluid from the sensor resulting from the change in the series resistance.
  • a pressure sensor element and methods of use are well known to one skilled in the art, for example the MEMS unit disclosed in U.S. Pat. No. 6,890,300 or U.S. Pat. No. 6,939,299.
  • Aspects of the present disclosure provide a gastric space filler device for treating obesity in a patient by reducing the stomach volume comprising an inflatable space filler and a safety element secured to the space filler, wherein the safety element yields a noticeable signal for causing a removal of the space filler, wherein at least a portion of an external surface of gastric space filler device is treated with melatonin.
  • a pressure sensor element to be mounted on a first of the at least two space fillers of gastric space filler device for sensing an internal pressure of the first space filler.
  • the pressure sensor element is mounted on the biodegradable space filler of gastric space filler device.
  • a pressure sensor element is mounted on any or all of the at least two space fillers of the present disclosure.
  • the pressure sensor element further comprises a transmitter for wirelessly transmitting the measured internal pressure to a receiver outside a body of the patient or recipient.
  • FIGS. 1-14 show embodiments of a gastric space filler device 19 and delivery tool for implanting and retrieving gastric space filler device 19 of the present disclosure.
  • FIG. i shows a stomach bubble or gastric space filler device 19 with two space fillers 21A, 21B secured to and in parallel to each other.
  • gastric space filler device 19 comprises two space fillers 21A, 21B, wherein second space filler 21B is enclosed within first space filler 21A, wherein at least a portion of first space filler 21A is made of a biodegradable material, optionally with a pressure sensor element (see, for example, FIG. 17) for measuring the pressure of first space filler 21A.
  • gastric space filler device 19 comprises two space fillers 21A, 21B, wherein second space filler 21B is enclosed within first space filler 21A, wherein at least a portion of first space filler 21A is made of a biodegradable material with a sensor element for measuring one or more properties of the contents of the first space filler, wherein the properties include pH, temperature, electrolyte type, electrolyte concentration, and the like.
  • the space between first space filler 21A and second space filler 21B is filled with a fluid or saline plus a dye or odor-producing mechanism for early detection that first space filler 21A is compromised, deflated, or has leaked.
  • connecting members 26A, 26B are made of flexible or elastic material. In another embodiment, connecting members 26A, 26B are made of solid material that allows no fluid communication between space fillers 21A, 21B.
  • a plunger is used to push gastric space filler device 19 out of the lumen of the delivery device.
  • the plunger of the delivery mechanism comprises a forward- pulling mechanism at the end distal to gastric space filler device 19. During the delivery phase, gastric space filler device 19 is under axial tension (i.e., under some pulling force between the distal end and the proximal end of the flexible space filler) to cause minimal circumferential profile for easy insertion into the sheath.
  • a plurality of connecting members 26A, 26B are disposed between second space filler 21B and first space filler 21A that is connected to infusing tube 23 via sealed inlet 20.
  • FIG. 2 shows an embodiment of first space filler 21A of FIG. 1 with a central passageway 33 therethrough.
  • gastric space filler device 19 comprises a plurality of passageways therethrough, wherein some passageways are connected to one another.
  • at least one connecting member 26A comprises a one-way check valve or seal enabling the fluid to flow from first space filler 21A into second space filler 21B, but preventing fluid from returning back to first space filler 21A.
  • gastric space filler device 19 is fabricated from polyurethane sheet material, wherein the polyurethane sheet material comprises a single layer. Particularly effective embodiments avoid seams and edges in gastric space filler device 19.
  • gastric space filler device 19 is made of a non-biodegradable material selected from polyester, polypropylene, Nylon, polyethylene, thermoplastic elastomer (TPE), silicone, latex, polyethylene, and copolymers thereof.
  • gastric space filler device 19 is a permanent implant.
  • gastric space filler device 19 of the present disclosure has a useful life of about 3 to 12 months.
  • gastric space filler device 19 is designed for safety using an inflatable balloon made of a biodegradable material, wherein the biodegradable material is selected from a group consisting of polymers or copolymers of lactide, glycolide, caprolactone, polydioxanone, trimethylene carbonate, methylene carbonate, polyorthoesters, and polyethylene oxide.
  • the biodegradable material is collagen, chitosan, elastin, gelatin, and combinations thereof.
  • FIG. 3 shows gastric space filler device 19 with two space fillers 22A,
  • Gastric space filler device 19 comprises plurality of connecting members 36 between second space filler 22B and the first space filler 22A, wherein first space filler 22A is connected to infusing tube 23 via a sealed inlet.
  • gastric space filler device 19 for treating obesity in a patient by reducing stomach volume comprising at least two flexible inflatable space fillers 22A, 22B secured to each other, each space filler 22A, 22B being inflatable to a volume inside stomach 40 and first space filler 22A is in one-way fluid communication with remaining other space fillers 22B, wherein at least a portion of the first space filler 22A is made of a biodegradable material.
  • a check valve permits the flow of fluid in only one direction from first space filler 22A through a conduit to second space filler 22B.
  • gastric space filler device 19 is shown with an embodiment of inflatable space filler 27 and plurality of radially expanded support elements 29 thereon, wherein each support element 29, comprises suspended space filler non-contact portion 29A and space filler contact portion 29B.
  • Radially expanded support elements 29 may be secured to each other via crossing bar 31 or other connecting mechanisms.
  • radially expanded support elements 29 are sized and configured to stabilize gastric space filler device 19 inside stomach 40 by distension against the stomach wall.
  • FIG. 5 shows a cross-sectional view of an exemplary support element 29 of FIG. 4.
  • support element 29 comprises meshed stenting structure 38 wrapped or enclosed with biocompatible elastomeric material 39, such as silicone, polyurethane, latex, and the like.
  • the elastomeric material comprises a high percentage of voids or micropores, like a sponge or foam.
  • meshed stenting structure 38 is similar to a cardiovascular stent that is either self-expandable or balloon expandable.
  • meshed stenting structure 38 is mechanically crimpable or may be made of temperature sensitive shape memory Nitinol.
  • FIG. 6 shows one embodiment of gastric space filler device 19 with two connected expandable elements 48, 49.
  • First expandable element 48 connects second expandable element 49 via a plurality of connecting members 47.
  • first expandable element 48 and second expandable element 49 are not in fluid communication.
  • infusion port 46 is provided for infusion of a fluid, such as saline, or other substances into gastric space filler device 19. Infusion port 46 would be known and understood by a person of ordinary skill in the art.
  • at least one of connecting members 47 has a lumen therethrough for fluid communication between expandable element 48 and expandable element 49.
  • at least one of expandable elements 48, 49 has central passageway 45 for food pass-through.
  • gastric space filler device 19 is sized and configured to fit stomach volume up to 90% (effectively 95%) of the available stomach volume.
  • peripheral surface 44A of first expandable element 48 or peripheral surface 44B of second expandable element 49 has a corrugated shape so as to contact the inner wall of stomach 40 at certain discrete lines (one dimension) of the corrugation, instead of contact areas (two dimensions).
  • second expandable element 49 is sized and shaped to distend against the inner wall of stomach 40 at a place spaced away from pyloric sphincter zone 43.
  • second expanded element 49 comprises a plurality of smooth- surfaced convex protrusions disposed to permit engagement of the stomach wall by gastric space filler 19 only at spaced localities, for minimizing mechanical trauma of the stomach wall by gastric space filler 19.
  • FIGS. 8 and 9 show gastric space filler device 19 with a shape retention mechanism made of different material as compared to the inflatable filler material.
  • gastric space filler device 19 comprises two toroid space fillers 73, 74.
  • first toroid space filler 73 and second toroid space filler 74 become one overall balloon-like space filler wrapped over shape retention mechanism 72 and connected by balloon- enclosed middle section ⁇ .
  • shape retention mechanism 72 may further comprise spring-like coil 75 that is semi-compressible and configured to resist compressive pressure from the stomach wall, but is flexible and collapsible by a retrievable instrument either through clamping, crimping, drawing string technique (as shown in FIGS. 10 and 11), or other mechanical destructive methods as would be known and understood by artisans.
  • Shape retention mechanism 72 may be made of Nitinol or other resilient and flexible metal or polymer.
  • shape retention mechanism 72 of gastric space filler device 19 may comprise at least one rib or properly sized protrusion secured at the exterior surface or at the interior surface of toroid space fillers 73) 74 or of gastric space filler device 19 generally.
  • Balloon-like space fillers are generally manufactured by dip coating a mandrel into silicone solution a few times to build up the thickness.
  • silicone compatible adhesive is generally used, for example, RTV silicone or moderate temperature curing silicone adhesive.
  • FIG. 10 there is illustrated an embodiment of gastric space filler device 19 having a mechanism of mechanically crimping the meshed stenting device 38.
  • a person of ordinary skill in the art will know and understand that the embodiment shown in FIG. 10 is applicable to gastric space filler devices 19 having more than one space fillers.
  • a support element is arranged and configured to be crimped circumferentially or radially inwardly to a smaller profile, together with deflated gastric space filler device 19, configured to be disposed in delivery catheter sheath 25 prior to delivery of gastric space filler device 19 in stomach 40 of a patient.
  • the support element self-expands after releasing the constraint thereon from catheter sheath 25, along with inflated gastric space filler device 19, to occupy an appropriate space inside stomach 40.
  • a retriever instrument with certain crimping capability is advanced into stomach 40 to orient the support element and to crimp the element to a small profile configured to be retracted within the lumen of the retriever instrument (for example, a retrieving catheter sheath).
  • Deflated gastric space filler device 19, and together with the crimped supporting elements may then be withdrawn from stomach 40 to outside the body of the patient.
  • FIG. 10 shows an embodiment of gastric space filler device 19 whereas FIG. 11 shows another embodiment of an gastric space filler device 19.
  • gastric space filler device 19 comprises drawstring 60 coupled to the plurality of rings 62, 63, 64 that are secured to gastric space filler device 19.
  • rings 62, 63, 64 may be an integral part of gastric space filler device 19.
  • Distal end-knot 65 of drawstring 60 is sized larger than the opening of distal ring 64.
  • Distal end-knot 65 keeps the distal end of drawstring 60 tight around distal ring 64.
  • gastric space filler device 19 When proximal section of drawstring 60A is pulled away from gastric space filler device 19 through proximal ring 62, gastric space filler device 19 becomes smaller radially or spirally.
  • conical shaped blocker 61 can pass the ring in a one-way, ratcheting manner, as would be known to artisans.
  • the volume of gastric space filler device 19 becomes irreversibly smaller each time conical shaped blocker 61 passes proximal ring 62.
  • trough 67 may be sized and configured to prevent drawstring 60 and rings 62, 63, 64 from protruding beyond the outermost external surface of gastric space filler device 19.
  • FIG. 12A shows an embodiment of multi-balloon gastric space filler device 19.
  • FIG. 12B shows another embodiment of multi-balloon gastric space filler device 19. As shown in FIG. 12A, multi-balloon gastric space filler device
  • multi-balloon gastric space filler device 19 may comprise individual balloons 81A, 81B, 81C, 81D (or individual space fillers) that have one or more sizes or are arranged in different planes.
  • balloon 81D may not lie in the same plane bounded by balloons 81A, 81B, and 81C.
  • Balloons connect to each other by one or more connecting members 82.
  • multi-balloon gastric space filler device 19 has at least one fluid infusing connector 83, which may comprise a valve or other suitable implements that would be known to artisans. Infusing connector 83 is effectively reverted or configured into a recess of gastric space filler device 19, such that it does not contact stomach walls.
  • multi-balloon gastric space filler device 19 comprises multi-valves (not shown) for inflation through middle channel 82, fills at least two balloons 81A, 81B, 81C, 81D independently.
  • FIG. 13A a free-floating gastric space filler device 19.
  • FIG. 13B exemplifies simulated placement of gastric space filler device 19 of FIG. 13A in stomach 40 at three different locations 19A, 19B, 19C.
  • Gastric space filler device 19 is sized and configured to be retained in the main portion of stomach 40. Free-floating gastric space filler device 19 so configured prevents the catastrophic or life-threatening blocking/ obstructing of pylorus 42.
  • Fluid infusing element 86 is sized and configured for easy fluid infusion with infusing port 87 that is revertable to be in a recess.
  • free-floating gastric space filler device 19 is retracted within a delivery apparatus with the infusing port pointing toward a distal end of the delivery apparatus. After delivery in stomach 40, gastric space filler device 19 is oriented such that the wide portion of gastric space filler device 19 is furthest from pylorus sphincter zone 43.
  • non-floating gastric space filler device 19 is shown, as well as a simulated placement of gastric space filler device 19 in stomach 40.
  • Non-floating gastric space filler device 19 comprises first end-ring 89A, second end-ring 89B, and necked down middle portion 91 with flow-through channel 90.
  • Either first end-ring 89A, second end-ring 89B, or both are semi-rigid, sized, and configured to maintain the device retention capability within stomach 40 after expansions.
  • Each end-ring 89A, 89B may be a balloon inflatable member or made with shape-memory Nitinol material to assert adequate extending force against the stomach wall for device retention within stomach 40.
  • gastric space filler device 19 comprises at least two space fillers 22A and 22B, for example, connected by means of connecting members 36.
  • space fillers 22A and 22B for example, connected by means of connecting members 36.
  • space fillers any of space fillers disclosed herein, including 21A, 21B, 22A, 22B, 27, 44A, 44B, 73, 74, as well as other equivalents, may be deployed from standard catheter sheath 25 in any number of embodiment configurations.
  • infusing tube 23 serves as a pushing plunger for pushing gastric space filler device 19 into stomach 40 of the patient.
  • gastric space filler devices 19 are filled with saline osmotically balanced fluid, fluid, or other substances depending on the embodiment, via infusing tube 23 from an external source.
  • the apparatus of the present disclosure may then be used to treat obesity in patients by: (A) providing an inflatable gastric space filler device 19 with infusing tube 23 releasably attached thereto inside elongate catheter sheath 25, wherein gastric space filler device 19 comprises at least two flexible inflatable space fillers 22A, 22B, for example, secured to each other, along with optional safety element 22C, with first space filler 22A being inflatable to a volume inside stomach 40 wherein at least a portion of first space filler 22A is made of a biodegradable material; (B) introducing catheter sheath 25 through the mouth and into stomach 40; (C) urging gastric space filler device 19 out of catheter sheath 25 and into stomach 40; (D) inflating space fillers 22A, 22B through infusing tube 23 with a given amount of fluid, saline, or other substance to increase the volume thereof; and (E) removing infusing tube 23 from stomach 40 and out through the mouth.
  • Catheter sheath 25 or delivery device for gastric space filler device 19 passes through esophagus 24 and cardiac notch 42 into stomach 40 of a patient.
  • space fillers 22A, 22B are inflated.
  • at least one of exemplary space fillers 22A, 22B is non-compliant and is inflated to a pressure slightly higher than the local atmospheric pressure or stomach 40 pressure, effectively to a pressure difference of about 1-20 mmHg, and more effectively to about 1-5 mmHg.
  • One rationale of a higher pressure for exemplary space fillers 22A, 22B is to maintain the desired occupied stomach volume, though the internal pressure might fractionally drift over the course of implantation.
  • the other substance infused into gastric space filler device 19 is a hydrogel, such as methylcellulose.
  • Methylcellulose (MC) is a water-soluble polymer derived from cellulose, the most abundant polymer in nature. As a viscosity-enhancing polymer, it thickens as a solution without precipitation over a wide pH range.
  • MC methylcellulose
  • These functional hydrogels may change their structures as they expose to varying environment, such as temperature, pH, or pressure. MC gels from aqueous solutions upon heating or salt addition (Langmuir 18:7291, 2002; Langmuir 20:6134, 2004).
  • PC Phosphorylcholine
  • gastric space filler device 19 coated with an immobilized antibody such as CD34 or the like
  • an immobilized antibody such as CD34 or the like
  • a method of treating obesity in a patient with minimal nausea effects comprising implanting a gastric space filler device 19 coated with an anti-nausea agent, wherein the anti-nausea agent may be melatonin, albumin, or phosphorylcholine to mimic a biological surface.
  • gastric space filler device 19 is treated with an anti-acid substance or an anti- adhesion substance.
  • gastric space filler device 19 has a central opening extending therethrough or gastric space filler device 19 is sized to occupy at least 90% of stomach volume of the patient.
  • gastric space filler device 19 has an adjustable volume and is sized and configured to occupy up to 90% of stomach volume (effectively 95%) of the patient.
  • Gastric space filler device 19 should be able to be increased in size over time through port infusion or re-docking infusion, as would be known to artisans.
  • gastric space filler device 19 may be adjusted over time to allow initial acceptance by stomach 40 and increased volume to achieve the right balance between weight loss and the lack of nausea and vomiting.
  • an external surface of gastric space filler device 19 is treated with an anti-acid substance, corrosion-resistant substance, or anti-adhesion substance, wherein the substance comprises polytetrafluoro-ethylene, inert material, or other biological material (such as albumin, melatonin, phosphorylcholine, immobilized antibody, or proteins) that are biocompatible.
  • Methods of treating the surface include coating, painting, dipping, impregnation, and the like.
  • the melatonin or phosphorylcholine coating is on at least a portion of the outer surface of gastric space filler device 19.
  • the melatonin or phosphorylcholine coating is on at least the portion of the outer surface of gastric space filler device 19 that contacts the stomach wall.
  • Gastric space filler device 19 may be coated with peptides to induce a feeling a satiety in patients, according to embodiments.
  • Gastric space filler device 19 may also be made of or surface coated with, polyolefin family like high density polyethylene; linear low density polyethylene; and ultra-high molecular weight polyethylene; fluoropolymer materials, like fluorinated ethylene propylene, polymethylpentene, polysulphons; or some elastomers such as thermoplastic polyurethanes and C-Flex type block copolymers.
  • delivery catheter sheath 25 may be treated to be hydrophilic or to have reduced surface friction.
  • delivery catheter sheath 25 (or a retrieval apparatus) has a low profile, lubricated exterior surface or interior surface, providing for comfort when used with non-sedated patients, for example.
  • Gastric space filler device 19 has sealed inlet 20 that allows fluid or saline to be infused into space fillers 21A, 21B via infusing tube 23 or a needle connected to infusing tube 23 that is connected to an external fluid source.
  • sealed inlet 20 is made of a self-sealing substance to facilitate puncture thereof with a needle for inflating space filler 21A, 21B and sealing off the puncture upon removal of the needle.
  • sealed inlet 20 is equipped with a one-way check valve for receiving infusing fluid or saline. Artisans will understand the applicability of these principles to each of embodiments disclosed herein, as well as equivalents.
  • melatonin may reduce nausea associated with implantation of gastric space filler device 19.
  • Melatonin is a sleep promoting agent that is involved in the regulation of gastrointestinal motility and sensation.
  • melatonin was orally administered 3 mg at bedtime for two weeks, those patients with melatonin regimen show significant attenuation in abdominal pain and reduced sensitivity in rectal pain as compared to the control group with placebo.
  • Tether 55 extends through a front side and a backside of each crossing point alternately. Tether 55 is then joined in loop 56 with one end of the tether extending through loop 56 in the other end of the tether and extending slightly out of the plane with end loop 57.
  • end loop 57 is snatched or grasped by a retriever apparatus (such as the apparatus having a hook, a grasper, or the like) and pulled toward outside of the mouth, enabling collapsing circumferentially the stenting structure to a much smaller profile for removal out of the body.
  • a retriever apparatus such as the apparatus having a hook, a grasper, or the like
  • biodegradable portion of the biodegradable space filler is sized and configured to biodegrade at a specified time duration, the biodegradation of the biodegradable space filler and its subsequent deflation serving as a warning signal for retrieving gastric space filler device 19.
  • a safety feature when pressure sensors on space fillers emit a low-pressure signal as a result of space filler deflation.
  • gastric space filler device 19 might be retrieved at a predetermined post- implantation time, for example at 6 months post-implantation.
  • gastric space filler device 19 for treating obesity in a patient by reducing stomach volume comprising inflatable space filler with a reference shape that is substantially maintained after gastric space filler device 19 is deflated by accident or intentionally.
  • maintenance of the reference shape of gastric space filler device 19 occurs due to the incorporation of a relatively rigid supportive spiral ridgeline along the interior surface of gastric space filler device 19.
  • the supportive ridgeline is similar to the reinforcing spiral elements along an internal surface of a hose.
  • the ridgeline is sized (at least one complete hoop circle) and configured to resist compressive pressure from the stomach wall, but is flexible and collapsible by a retrievable instrument either through clamping, crimping, drawing string technique, or other mechanical destructive methods.
  • the ridgeline is made of the same biocompatible material as gastric space filler device 19.
  • the ridgeline is an integral part of gastric space filler device 19.
  • the ridgeline contains a wholly enclosed elastic metal wire or coil by the same biocompatible material of gastric space filler device 19.
  • the device for maintaining the reference shape of gastric space filler device 19 incorporates a plurality of relatively rigid cross bars inside the interior space of gastric space filler device 19, wherein each end of the cross bars is secured to the interior wall of gastric space filler device 19.
  • the structure of the cross bars is sized and configured to resist compressive pressure from the stomach wall, but is flexible and collapsible by a retrievable instrument either through clamping, crimping, or other mechanical destructive methods.
  • the cross bar is made of the same biocompatible material as gastric space filler device 19.
  • the device for maintaining the reference shape of gastric space filler device 19 is to incorporate a foam material inside the interior volume of gastric space filler device 19.
  • the structure of the foam material is sized and shaped to resist compressive pressure from the stomach wall, but is flexible and collapsible by a retrievable instrument either through clamping, crimping, drawing string technique (as shown in FIGS. 10 or 11), or other mechanical methods.
  • FIG. 17 shows an embodiment of space filler 21A (see, e.g., FIG. 2) having pressure sensor element 51.
  • Pressure sensor elements 51 may be suitable pressure sensors as known to a person of ordinary skill in the art, for example the pressure sensor disclosed in U.S. Pat. No. 6,890,300.
  • Pressure sensor element 51 may be mounted on space filler 21A in accordance with the principles of the present disclosure or as known to artisans.
  • space filler 21A comprises recess area 50 sized and configured to appropriately receive and mount pressure sensor element 51.
  • Pressure sensor element 51 is in pressure communication with internal void 53 via opening 52.
  • gastric space filler device 19 may comprise flexible inflatable space filler 22A and safety element 22C, which are connected to space filler 22A, wherein safety element 22C yields a noticeable signal for causing removal of gastric space filler device 19.
  • safety element 22C is a visible dye that, when gastric space filler device 19 is compromised, causes a visible change to the appearance of urine shortly after gastric space filler device 19 is breached.
  • safety element 22C comprises an odor that, when gastric space filler device 19 is compromised or leaked, causes an odor in the urine shortly after breach of gastric space filler device 19.
  • safety element 22C comprises biodegradable material that, when safety element 22C biodegrades prematurely, yields a signal for prompt removal of the decomposed/biodegraded pieces.
  • Safety element 22C may also comprise a pressure sensor element for sensing an internal pressure of space filler 22A, as previously described.
  • the pressure sensor element may further comprise a transmitter for wirelessly transmitting a measured internal pressure to a receiver outside a body of the patient.
  • safety element 22C comprises a pH sensor element for sensing a pH of stomach 40 of the patient, wherein the pH sensor element may further comprise a transmitter for wirelessly transmitting the sensed pH to a receiver outside a body of the patient.
  • the sensed pH or the change of the sensed pH with respect to time is compared to the historic data or predetermined data for assessing device performance or integrity. If the sensed pH is below the threshold number for a predetermined period, this signal may prompt retrieval of gastric space filler device 19.
  • Safety element 22C may comprise device for maintaining the shape of gastric space filler device 19 so the compromised gastric space filler device 19 (either via leaking or collapsing) does not cause bowel obstruction.
  • Safety element 22C may maintain the residual cross-sectional shape or circumference dimension after a filler compromise, for example as shown in an embodiment shown in FIG. 4. In an embodiment, the appropriate dimension retention is at least 50%, to 75%, of the pre-compromised reference value.
  • gastric space filler device 19 and safety element 22C are configured to be in tandem inside stomach 40.
  • gastric space filler device 19 and safety element 22C are configured to be substantially parallel to each other.
  • safety element 22C or gastric space filler device 19 containing safety element 22C is anchored to or anchored through an inner wall of stomach 40. Artisans will understand and appreciate these principles and the related implementations.
  • safety element 22C or space filler (e.g., 21A, 21B) of gastric space filler device 19 is ultrasonically visible.
  • an ultrasonic transducer is mounted on either the safety element or gastric space filler device 19 for emitting an ultrasonic signal.
  • aspects of the present disclosure relate to an anchoring or securing mechanism of gastric space filler device 19 that anchors only when gastric space filler device 19 is adequately inflated.
  • at least one of (e.g., 21A, 21B) space fillers of gastric space filler device 19 is anchored to an inner wall of stomach 40.
  • the anchoring action is arranged and configured to activate the anchoring mechanism (such as from a piercing needle) when gastric space filler device 19 is inflated while contacting the inner wall of stomach 40, and to reverse the anchoring mechanism when the filler is deflated.
  • Inflated gastric space filler device 19 is maintained within or stabilized by anchoring or otherwise securing the expandable device to the stomach walls.
  • such expandable devices have tethering regions for attachment to the one or more fasteners which can be configured to extend at least partially through one or several folds of the patient's stomach wall as would be known to artisans.
  • Such fasteners can be formed in a variety of configurations, e.g., helical, elongate, ring, clamp, and they can be configured to be non-piercing. Persons of ordinary skill will understand how to anchor gastric space filler device 19 to stomach wall and the attendant issues related to anchoring.

Landscapes

  • Health & Medical Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Nursing (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

La présente invention concerne un lest gastrique permettant de traiter un patient contre l'obésité par réduction du volume gastrique. Ce dispositif est constitué du lest gonflable proprement-dit et d'un élément de sécurité solidaire du dispositif et capable de produire un signal pour provoquer l'enlèvement du lest.
EP06827313.5A 2005-10-31 2006-10-31 Lest intragastrique Withdrawn EP1948076A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/263,302 US20070100368A1 (en) 2005-10-31 2005-10-31 Intragastric space filler
US11/262,614 US20070100367A1 (en) 2005-10-31 2005-10-31 Intragastric space filler
US11/315,925 US20070100369A1 (en) 2005-10-31 2005-12-22 Intragastric space filler
PCT/US2006/042710 WO2007053706A1 (fr) 2005-10-31 2006-10-31 Lest intragastrique

Publications (2)

Publication Number Publication Date
EP1948076A1 true EP1948076A1 (fr) 2008-07-30
EP1948076A4 EP1948076A4 (fr) 2014-08-27

Family

ID=38006201

Family Applications (5)

Application Number Title Priority Date Filing Date
EP16153659.4A Withdrawn EP3085341A1 (fr) 2005-10-31 2006-10-31 Lest intragastrique
EP15198773.2A Withdrawn EP3056173A1 (fr) 2005-10-31 2006-10-31 Implant pour le remplissage de l'espace intragastrique
EP06827314.3A Not-in-force EP1948077B1 (fr) 2005-10-31 2006-10-31 Lest intragastrique
EP06827093.3A Active EP1948075B1 (fr) 2005-10-31 2006-10-31 Lest intragastrique
EP06827313.5A Withdrawn EP1948076A4 (fr) 2005-10-31 2006-10-31 Lest intragastrique

Family Applications Before (4)

Application Number Title Priority Date Filing Date
EP16153659.4A Withdrawn EP3085341A1 (fr) 2005-10-31 2006-10-31 Lest intragastrique
EP15198773.2A Withdrawn EP3056173A1 (fr) 2005-10-31 2006-10-31 Implant pour le remplissage de l'espace intragastrique
EP06827314.3A Not-in-force EP1948077B1 (fr) 2005-10-31 2006-10-31 Lest intragastrique
EP06827093.3A Active EP1948075B1 (fr) 2005-10-31 2006-10-31 Lest intragastrique

Country Status (8)

Country Link
EP (5) EP3085341A1 (fr)
JP (2) JP2009513305A (fr)
CA (4) CA2638989A1 (fr)
DK (2) DK1948077T3 (fr)
ES (2) ES2565586T3 (fr)
HU (1) HUE028842T2 (fr)
PL (1) PL1948075T3 (fr)
WO (3) WO2007053707A1 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8845672B2 (en) 2002-05-09 2014-09-30 Reshape Medical, Inc. Balloon system and methods for treating obesity
US8585771B2 (en) 2004-02-26 2013-11-19 Endosphere, Inc. Methods and devices to curb appetite and/or to reduce food intake
US8147561B2 (en) 2004-02-26 2012-04-03 Endosphere, Inc. Methods and devices to curb appetite and/or reduce food intake
US20070100368A1 (en) 2005-10-31 2007-05-03 Quijano Rodolfo C Intragastric space filler
US9060835B2 (en) 2006-05-26 2015-06-23 Endosphere, Inc. Conformationally-stabilized intraluminal device for medical applications
US8142469B2 (en) 2007-06-25 2012-03-27 Reshape Medical, Inc. Gastric space filler device, delivery system, and related methods
US20110137227A1 (en) 2007-07-16 2011-06-09 Mckinley James T Methods and devices for delivering or delaying lipids within a duodenum
US20090171383A1 (en) * 2007-12-31 2009-07-02 David Cole Gastric space occupier systems and methods of use
CA2749778C (fr) 2008-01-29 2021-06-15 Milux Holding S.A. Dispositif, systeme et methode de traitement de l'obesite
US8226593B2 (en) 2008-04-09 2012-07-24 E2 Llc Pyloric valve
US8100850B2 (en) 2008-04-09 2012-01-24 E2 Llc Pyloric valve devices and methods
US8579987B2 (en) * 2008-10-10 2013-11-12 Milux Holding Sa Artificial stomach
US9174031B2 (en) 2009-03-13 2015-11-03 Reshape Medical, Inc. Device and method for deflation and removal of implantable and inflatable devices
EP2414025A4 (fr) 2009-04-03 2017-08-02 ReShape Medical, Inc. Charges améliorées de l'espace intragastrique et procédés de préparation, comprenant des tests in vitro
US9358143B2 (en) 2009-07-22 2016-06-07 Reshape Medical, Inc. Retrieval mechanisms for implantable medical devices
WO2011011741A2 (fr) 2009-07-23 2011-01-27 Reshape Medical, Inc. Mécanismes de gonflage et de dégonflage pour dispositifs médicaux gonflables
EP2456505B1 (fr) 2009-07-23 2017-05-24 ReShape Medical, Inc. Dégonflage et retrait de dispositif médicaux implantables
EP2480279A4 (fr) 2009-09-24 2017-11-15 Reshape Medical, Inc. Normalisation et stabilisation de surfaces de ballonnet pour dégonflement
EP2490746B1 (fr) 2009-10-21 2019-03-27 Apollo Endosurgery, Inc. Dispositif bariatrique de perte de poids
EP2533846B1 (fr) 2010-02-08 2018-08-22 ReShape Medical LLC Matériaux et procédés pour dispositifs améliorés à ballon intragastrique
US9622896B2 (en) 2010-02-08 2017-04-18 Reshape Medical, Inc. Enhanced aspiration processes and mechanisms for instragastric devices
WO2011106637A1 (fr) 2010-02-25 2011-09-01 Reshape Medical, Inc. Procédés d'explantation améliorés et perfectionnés et mécanismes pour dispositifs intragastriques
WO2011116025A1 (fr) 2010-03-15 2011-09-22 Innovelle, Llc Dispositif bariatrique et méthode pour perdre du poids
US9629740B2 (en) 2010-04-06 2017-04-25 Reshape Medical, Inc. Inflation devices for intragastric devices with improved attachment and detachment and associated systems and methods
WO2012054519A2 (fr) 2010-10-18 2012-04-26 Allergan, Inc. Implants intra-gastriques réactifs
EP2629714B1 (fr) 2010-10-18 2015-12-30 Apollo Endosurgery, Inc. Implants intra-gastriques pourvus de pièces d'ancrage duodénal
US9463107B2 (en) 2010-10-18 2016-10-11 Apollo Endosurgery, Inc. Variable size intragastric implant devices
US8870966B2 (en) 2010-10-18 2014-10-28 Apollo Endosurgery, Inc. Intragastric balloon for treating obesity
US9233016B2 (en) 2010-10-18 2016-01-12 Apollo Endosurgery, Inc. Elevating stomach stimulation device
US8864840B2 (en) 2010-10-19 2014-10-21 Apollo Endosurgery, Inc. Intragastric implants with collapsible frames
US9198790B2 (en) 2010-10-19 2015-12-01 Apollo Endosurgery, Inc. Upper stomach gastric implants
US9398969B2 (en) 2010-10-19 2016-07-26 Apollo Endosurgery, Inc. Upper stomach gastric implants
US9498365B2 (en) * 2010-10-19 2016-11-22 Apollo Endosurgery, Inc. Intragastric implants with multiple fluid chambers
US8920447B2 (en) 2010-10-19 2014-12-30 Apollo Endosurgery, Inc. Articulated gastric implant clip
US9095405B2 (en) 2010-10-19 2015-08-04 Apollo Endosurgery, Inc. Space-filling intragastric implants with fluid flow
WO2012054522A2 (fr) 2010-10-19 2012-04-26 Allergan, Inc. Manchon duodénal ancré non perforant et systèmes d'administration
KR101872064B1 (ko) 2012-02-21 2018-07-31 얼루리언 테크날러지스 인코포레이티드 인체 내에 임시 임플란트를 배치하고 방출하기 위한 방법 및 디바이스
US10182932B2 (en) 2012-02-21 2019-01-22 Allurion Technologies, Inc. Methods and devices for deploying and releasing a temporary implant within the body
WO2015085011A1 (fr) 2013-12-04 2015-06-11 Obalon Therapeutics , Inc. Systèmes et procédés de localisation et/ou de caractérisation de dispositifs intragastriques
WO2016057716A1 (fr) * 2014-10-09 2016-04-14 Obalon Therapeutics, Inc. Systèmes et procédés ultrasonores pour la localisation et/ou la caractérisation de dispositifs intragastriques
WO2017044929A1 (fr) * 2015-09-11 2017-03-16 Parker-Haniifin Corporation Dispositif anti-reflux à déploiement endoscopique
CN108135719B (zh) * 2015-09-23 2020-06-05 赛纳兹医疗公司 用于治疗肥胖的胃内装置
US10350100B2 (en) 2016-04-12 2019-07-16 Obalon Therapeutics, Inc. System for detecting an intragastric balloon
KR101860681B1 (ko) 2017-09-25 2018-05-23 엔달리스 위내 풍선 삽입키트
US10470908B2 (en) 2018-02-26 2019-11-12 Allurion Technologies, Inc. Automatic-sealing balloon-filling catheter system
US11098813B2 (en) 2018-07-06 2021-08-24 Allurion Technologies, Inc. Binary fluid control valve system
CN113242723A (zh) 2018-12-13 2021-08-10 阿勒里恩科技公司 增强型流体输送系统

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4598699A (en) * 1985-06-10 1986-07-08 Garren Lloyd R Endoscopic instrument for removing stomach insert
WO2002040081A2 (fr) * 2000-11-17 2002-05-23 Syntheon, Llc Dispositif de type ballonnet intragastrique conçu pour voir varier son volume de façon iterative sans assistance exterieure
US20050055039A1 (en) * 2003-07-28 2005-03-10 Polymorfix, Inc. Devices and methods for pyloric anchoring

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133315A (en) 1976-12-27 1979-01-09 Berman Edward J Method and apparatus for reducing obesity
US4246893A (en) 1978-07-05 1981-01-27 Daniel Berson Inflatable gastric device for treating obesity
US4416267A (en) 1981-12-10 1983-11-22 Garren Lloyd R Method and apparatus for treating obesity
US4899747A (en) 1981-12-10 1990-02-13 Garren Lloyd R Method and appartus for treating obesity
US4485805A (en) * 1982-08-24 1984-12-04 Gunther Pacific Limited Of Hong Kong Weight loss device and method
US4763653A (en) * 1985-02-19 1988-08-16 Rockey Arthur G Medical sleeve
US4694827A (en) 1986-01-14 1987-09-22 Weiner Brian C Inflatable gastric device for treating obesity and method of using the same
US6939299B1 (en) 1999-12-13 2005-09-06 Kurt Petersen Implantable continuous intraocular pressure sensor
US6826428B1 (en) 2000-04-11 2004-11-30 The Board Of Regents Of The University Of Texas System Gastrointestinal electrical stimulation
US7033373B2 (en) * 2000-11-03 2006-04-25 Satiety, Inc. Method and device for use in minimally invasive placement of space-occupying intragastric devices
US6746460B2 (en) * 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
WO2004019773A1 (fr) 2002-08-27 2004-03-11 Michigan State University Manometre miniature implantable
US6981980B2 (en) * 2003-03-19 2006-01-03 Phagia Technology Self-inflating intragastric volume-occupying device
EP1682051B1 (fr) * 2003-10-23 2010-07-28 Proxy Biomedical Limited Appareil de constriction gastrique
US20070265709A1 (en) * 2004-02-25 2007-11-15 Mayo Foundatio For Medical Education And Research Gastric Bypass Devices and Methods
US7931693B2 (en) * 2004-02-26 2011-04-26 Endosphere, Inc. Method and apparatus for reducing obesity
AU2005231323B2 (en) * 2004-03-26 2011-03-31 Ethicon Endo-Surgery, Inc Systems and methods for treating obesity
US8066780B2 (en) * 2004-05-03 2011-11-29 Fulfillium, Inc. Methods for gastric volume control
US7803195B2 (en) * 2004-06-03 2010-09-28 Mayo Foundation For Medical Education And Research Obesity treatment and device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4598699A (en) * 1985-06-10 1986-07-08 Garren Lloyd R Endoscopic instrument for removing stomach insert
WO2002040081A2 (fr) * 2000-11-17 2002-05-23 Syntheon, Llc Dispositif de type ballonnet intragastrique conçu pour voir varier son volume de façon iterative sans assistance exterieure
US20050055039A1 (en) * 2003-07-28 2005-03-10 Polymorfix, Inc. Devices and methods for pyloric anchoring

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2007053706A1 *

Also Published As

Publication number Publication date
DK1948077T3 (en) 2016-04-04
JP2009131641A (ja) 2009-06-18
DK1948075T3 (en) 2016-05-09
EP1948075A1 (fr) 2008-07-30
HUE028842T2 (en) 2017-01-30
WO2007053707A1 (fr) 2007-05-10
CA2925648A1 (fr) 2007-05-10
JP2009513305A (ja) 2009-04-02
CA2640554A1 (fr) 2007-05-10
EP3085341A1 (fr) 2016-10-26
EP3056173A1 (fr) 2016-08-17
CA2638989A1 (fr) 2007-05-10
EP1948075A4 (fr) 2014-09-24
PL1948075T3 (pl) 2017-01-31
EP1948075B1 (fr) 2016-02-03
ES2570503T3 (es) 2016-05-18
WO2007053706A1 (fr) 2007-05-10
EP1948077A4 (fr) 2014-09-03
EP1948077A1 (fr) 2008-07-30
EP1948076A4 (fr) 2014-08-27
CA2638988C (fr) 2016-06-28
EP1948077B1 (fr) 2015-12-23
CA2638988A1 (fr) 2007-05-10
ES2565586T3 (es) 2016-04-05
WO2007053556A1 (fr) 2007-05-10

Similar Documents

Publication Publication Date Title
CA2638988C (fr) Lest intragastrique
EP1962941B1 (fr) Remplisseur d'espace intragastrique
US20190076282A1 (en) Intragastric space filler
US20070100367A1 (en) Intragastric space filler
CA2680124C (fr) Systeme de ballon intragastrique, procedes therapeutiques et produits
EP3305254A1 (fr) Implants gastriques s'étirant dans l'estomac
EP2629708B1 (fr) Dispositifs d'implant intragastrique de taille variable

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080530

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20140730

RIC1 Information provided on ipc code assigned before grant

Ipc: A61F 5/00 20060101ALI20140724BHEP

Ipc: A61F 2/04 20130101AFI20140724BHEP

17Q First examination report despatched

Effective date: 20150713

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: RESHAPE MEDICAL, INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: RESHAPE MEDICAL LLC

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20181009

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190220